c.i. 42510 has been researched along with Retinal Diseases in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 12 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartz-Schmidt, KU; Farecki, ML; Hurst, J; Januschowski, K; Schnichels, S; Spitzer, MS; Szurman, P | 1 |
GarcĂa-Aguirre, G; Henaine-Berra, A; Jimenez-Sierra, JM; Lechuga-Perezanta, R; Morales-Canton, V; Santos-Palacios, A; Sepulveda-Vazquez, H | 1 |
Coral, K; Karthikkeyan, G; Nareshkumar, RN; Ratra, D | 1 |
Enaida, H; Fujita, K; Hachisuka, Y; Ikeda, Y; Ishibashi, T; Kadonosono, K; Matsui, T; Nakao, S; Oshima, Y; Yoshida, S | 1 |
Alharthi, E; Azad, R; Bashshur, ZF; Bejjani, RA; Bertelli, E; Bouassida, B; Bourla, D; Bruinsma, M; Crespo, IC; Fahed, C; Fayyad, F; Frank, J; Melles, GR; Mohr, A; Mura, M; Nawrocki, J; Oellerich, S; Rivett, K; Scharioth, GB; Shkvorchenko, DO; Szurman, P; Van Wijck, H; Veckeneer, M; Wong, DS; Wong, IY | 1 |
Cattin, PC; Henrich, PB; Lang, C; Valmaggia, C | 1 |
Enaida, H; Hisatomi, T; Ikeda, Y; Ishibashi, T; Nakao, S; Yoshida, S | 1 |
Gerding, H | 1 |
Eibl, KH; Gandorfer, A; Haritoglou, C; Henrich, PB; Kampik, A; Schumann, RG | 1 |
Cattin, PC; Ferreira, PR; Flammer, J; Haritoglou, C; Henrich, PB; Josifova, T; Priglinger, SG; Strauss, RW | 1 |
Bastien, A; Folgar, AM; Kuhn, F; Pelayes, DE; Takahashi, W; Vinicius, PN; Zarate, JO | 1 |
Cattin, PC; Haritoglou, C; Henrich, PB; Lang, C; Priglinger, SG; Strauss, RW; Valmaggia, C | 1 |
2 review(s) available for c.i. 42510 and Retinal Diseases
Article | Year |
---|---|
Chromovitrectomy and vital dyes.
Topics: Coloring Agents; Humans; Indocyanine Green; Monitoring, Intraoperative; Retinal Diseases; Rosaniline Dyes; Vitrectomy; Vitreous Body | 2014 |
Acid Violet 17: a New Dye for Chromovitrectomy?
Topics: Animals; Coloring Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Intravitreal Injections; Male; Monitoring, Intraoperative; Prevalence; Rabbits; Retinal Diseases; Risk Factors; Rosaniline Dyes; Vitreoretinal Surgery | 2016 |
1 trial(s) available for c.i. 42510 and Retinal Diseases
Article | Year |
---|---|
Novel 'heavy' dyes for retinal membrane staining during macular surgery: multicenter clinical assessment.
Topics: Aged; Basement Membrane; Coloring Agents; Drug Combinations; Epiretinal Membrane; Female; Humans; Indicators and Reagents; Intraocular Pressure; Male; Polyethylene Glycols; Prospective Studies; Retinal Diseases; Rosaniline Dyes; Staining and Labeling; Trypan Blue; Visual Acuity; Vitrectomy | 2014 |
9 other study(ies) available for c.i. 42510 and Retinal Diseases
Article | Year |
---|---|
Negative Effects of Acid Violet-17 and MBB Dual In Vitro on Different Ocular Cell Lines.
Topics: Apoptosis; Cell Line; Cell Survival; Galanin; Humans; Intraoperative Period; Neuropeptide Y; Peptide Fragments; Retinal Diseases; Retinal Ganglion Cells; Retinal Pigment Epithelium; Rosaniline Dyes; Vitrectomy | 2017 |
Double Staining Technique With Brilliant Blue G and Its Effect on Ganglion Cells in Macular Pathology.
Topics: Aged; Female; Humans; Indicators and Reagents; Male; Prospective Studies; Reproducibility of Results; Retinal Diseases; Retinal Ganglion Cells; Rosaniline Dyes; Staining and Labeling; Tomography, Optical Coherence; Vitrectomy | 2019 |
Effect of brilliant Blue-G on cellular stress response in retinal pigment epithelial cells: In vitro.
Topics: Apoptosis; Cell Survival; Cells, Cultured; Cytokines; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Epithelial Cells; Humans; Indicators and Reagents; Reactive Oxygen Species; Retinal Diseases; Retinal Pigment Epithelium; Rosaniline Dyes; Vitreoretinal Surgery | 2019 |
Clinical evaluation and feasibility of changing intraoperative visibility with a novel viewing filter system for human eye.
Topics: Diabetic Retinopathy; Epiretinal Membrane; Feasibility Studies; Filtration; Humans; Image Enhancement; Indicators and Reagents; Intraoperative Period; Macular Edema; Microscopy; Phacoemulsification; Pilot Projects; Retinal Detachment; Retinal Diseases; Retinal Perforations; Retrospective Studies; Rosaniline Dyes; Vitrectomy | 2013 |
The price for reduced light toxicity: Do endoilluminator spectral filters decrease color contrast during Brilliant Blue G-assisted chromovitrectomy?
Topics: Aged; Aged, 80 and over; Basement Membrane; Contrast Sensitivity; Female; Filtration; Humans; Indicators and Reagents; Lighting; Male; Middle Aged; Prospective Studies; Radiation Injuries; Retina; Retinal Diseases; Rosaniline Dyes; Vitrectomy; Vitreoretinal Surgery | 2014 |
Sequential epiretinal membrane removal with internal limiting membrane peeling in brilliant blue G-assisted macular surgery.
Topics: Aged; Aged, 80 and over; Epiretinal Membrane; Female; Humans; Indicators and Reagents; Macula Lutea; Male; Microscopy, Electron, Transmission; Middle Aged; Retinal Diseases; Rosaniline Dyes | 2010 |
Quantification of Contrast Recognizability during Brilliant Blue G- and Indocyanine Green-Assisted Chromovitrectomy.
Topics: Aged; Aged, 80 and over; Coloring Agents; Contrast Media; Epiretinal Membrane; Female; Humans; Indicators and Reagents; Indocyanine Green; Intraoperative Period; Male; Middle Aged; Retinal Diseases; Retrospective Studies; Rosaniline Dyes; Staining and Labeling; Vitrectomy | 2011 |
Staining of the internal limiting membrane with the use of heavy brilliant blue G.
Topics: Basement Membrane; Biomarkers; Coloring Agents; Diabetic Retinopathy; Female; Humans; Macular Edema; Male; Retinal Diseases; Retinal Perforations; Rosaniline Dyes; Staining and Labeling; Vitrectomy | 2012 |
Contrast recognizability during brilliant blue G - and heavier-than-water brilliant blue G-assisted chromovitrectomy: a quantitative analysis.
Topics: Aged; Aged, 80 and over; Basement Membrane; Deuterium Oxide; Epiretinal Membrane; Female; Humans; Indicators and Reagents; Male; Middle Aged; Prospective Studies; Retinal Diseases; Rosaniline Dyes; Vitrectomy | 2013 |